The fires affected millions of people in the region. It could take years to understand the health consequences, but ongoing ...
Scientists may have pinpointed a way to reverse Alzheimer’s disease in an animal study. The study, led by University Hospitals Cleveland Medical Center, found that restoring a central cellular energy ...
View post: This Simple Swinging Exercise Can Fix Years of Bad Posture View post: Jack Daniel’s Latest Distillery Series Release Is Its Sweetest Experiment Yet—and It'll Be Gone Before You Know It Jack ...
Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
Easy test identifies high stress levels in kids living with chronic illness By Paul McClure September 16, 2025 A simple test can detect if kids with chronic diseases are stressed and at risk of mental ...
Children with systemic juvenile idiopathic arthritis (sJIA; Still disease) and those with rheumatoid factor (RF)-positive polyarthritis exhibiting high disease activity had higher serum ferritin ...
If there's one piece of automotive technology that really feels more like The Future than anything else, it's the automated driving systems that have quickly proliferated across the industry. Commonly ...
Measles cases in the United States have reached their highest level in 25 years, with more than 1,270 confirmed cases this year. That number surpasses the last record of 1,274 cases set in 2019, ...
Microplastics are tiny plastic pieces less than 5 millimeters in length. Coastal counties with very high marine microplastic levels had higher rates of diabetes, heart disease, and stroke compared to ...
Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of soot-like carbon deposits compared to cells taken from people who smoke but do not ...
TARRYTOWN, N.Y. and PARIS, May 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use ...